Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etomidate-fentanyl-midazolam versus propofol-fentanyl-midazolam sedation for cataract surgery
IRCT20240710062387N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of etomidate, propofol, fentanyl and midazolam in cataract (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Sedation score, Surgeon satisfaction and 1 more. Started Aug 2024; status: completed.
02
Drugs
etomidatepropofolfentanylmidazolam
03
Conditions
cataract
Beyond the preview
Go deeper on IRCT20240710062387N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240710062387N1.